期刊文献+

体外小胶质细胞活化及MRP8表达关系的研究 被引量:1

Relationship between microglia activation and MRP8 expression in vitro
下载PDF
导出
摘要 目的建立体外小胶质细胞糖氧剥离活化模型,并探讨小胶质细胞活化与MRP8表达的关系。方法体外培养大鼠原代小胶质细胞,糖氧剥离(OGD)法建立小胶质细胞活化模型,通过形态学观察、MTT法检测不同OGD时间点小胶质细胞活力改变,实时荧光定量PCR法检测不同时间点小胶质细胞MRP8相对表达量。结果小胶质细胞OGD培养5min后细胞开始活化,活力较正常对照组明显增加(P<0.05),且在10min组细胞活力最大,OGD培养15min、30min、60min后细胞活力明显下降(P<0.05)。MRP8在小胶质细胞中表达随着OGD时间延长先增加后降低,在10min组达高峰(P<0.05)。结论首次在体外证实活化的小胶质细胞表达MRP8增加,这可能是其参与多种中枢神经系统疾病发病的机制之一。 Objective To establish microglial activation model in vitro by glucose-oxygen deprivation and explore the relationship between microglia activation and expression of MRP8. Methods First prepared primary cultured rat micro- glial cells. Microglial activation model was established by oxygen-glucose deprivation (OGD) mehtod. Using morphological observation, microglia viability at different OGD time points was tested by MTT assay. Real time PCR method was used to detect the relative expression of MRP8 at different time points. Results Microglia cells began to activate and the viability of microglia cells increased obviously( P 〈 0.05) after 5rain of OGD, was the highest at 10rain. Then decreased significantly after longer times (15,30, 60rain) of OGD(P 〈 0.05). The expression of MRP8 in microglia cells increased at first to reach the peak at 10rain ( P 〈 0.05 ), then decreased as the OGD time extended. Conclusion We firstly confirmed that ac- tivated microglia expressed higher MRP8 in vitro. This may be an important pathogenesis for microglia cells participating in many central nervous system disease development.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2013年第12期1060-1063,共4页 Journal of Apoplexy and Nervous Diseases
基金 国家自然科学基金(No.81171226)
关键词 小胶质细胞 糖氧剥离 MRP8 Microglia Oxygen-glucose deprivation Myeloid related protein-8
  • 相关文献

参考文献19

  • 1Dheen ST,Kaur C,Ling EA. Microglial activation and its implications in the brain diseases[J].{H}Current Medicinal Chemistry,2007,(11):1189-1197.
  • 2Yang I,Han SJ,Kaur G. The role of microglia in central nervous system immunity and glioma immunology[J].{H}Journal of Clinical Neuroscience,2010,(01):6-10.
  • 3Tambuyzer BR,Ponsaerts P,Nouwen EJ. Microglia:gatekeepers of central nervous system immunology[J].{H}Journal of Leukocyte Biology,2009,(03):352-370.
  • 4Zimmer DB,Eubanks JO,Ramakrishnan D. Evolution of the S100 family of calcium sensor proteins[J].{H}Cell Calcium(Edinburgh),2013,(03):170-179.
  • 5徐玉东,尹磊淼,王宇,魏颖,杨永清.S100A8蛋白在炎症中的作用[J].生理学报,2012,64(2):231-237. 被引量:4
  • 6Okun E,Griffioen K J,Mattson MP. Toll-like receptor signaling in neural plasticity and disease[J].{H}TRENDS IN NEUROSCIENCES,2011,(05):269-281.
  • 7Engel S,Schluesener H,Mittelbronn M. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14[J].{H}Acta Neuropathologica,2000,(03):313-322.
  • 8向秋莲,张慈柳,彭镜,何芳,吴丽文,欧曼,尹飞.TLR4、MRP8在内侧颞叶癫痫幼大鼠海马中表达的动态变化[J].中风与神经疾病杂志,2012,29(7):580-584. 被引量:6
  • 9孔惠敏,甘娜,彭镜,何芳,马玉平,尹飞.一种改良的新生大鼠小胶质细胞原代培养方法[J].神经解剖学杂志,2013,29(4):391-394. 被引量:3
  • 10Polarzi E,Monti B. Microglia and neuroprotection:from in vitro studies to therapeutic applications[J].{H}Progress in Neurobiology,2010,(03):293-315.

二级参考文献99

  • 1徐燕,王颖,黄远桂,饶志仁.在戊四氮致痫大鼠早期前脑中OX-42和Fos蛋白的表达变化[J].神经解剖学杂志,2006,22(1):55-61. 被引量:2
  • 2Adams HP,Del Zoppo GJ,Alberts MJ,et al.Guidelines for the early management of adults with ischemic stroke:a guideline from the American Heart Association/American Stroke Council,Clinical Cardiology Council,Cardiovasaular Radiology and Intervention Council,and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups:The American Academy of Neurology Affirms the value of this guideline as an educational tool for neurologists[J].Circulation,2007,115(20):e478-e534.
  • 3Kaur J,Zhao ZH,Klein GM,et al.The neurotoxicity of tissue plasminogen activator?[J].J Cerebr Blood Met,2004,24:945-963.
  • 4Kidwell CS,Latour L,Saver JL,et al.Thrombolytic toxicity:blood brain barrier disruption in human ischemic stroke[J].Cerebrovasc Dis,2008,25:338-343.
  • 5Adibhatla RM,Hatcher JF.Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke:therapeutic strategies[J].CNS Neurol Disord-Dr,2008,7(3):243-253.
  • 6Wang X,Rosell A,Lo EH.Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy[J].CNS Neurol Disord-Dr,2008,7(3):235-242.
  • 7Sheehan JJ,Tsirka SE.Fibrin-modifying serine proteases thrombin,tPA,and plasmin in ischemic stroke:a review[J].GLIA,2005,50(4):340-350.
  • 8Siao CJ,Femandez SR,Tsirka SE.Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury[J].Neurosci,2003,23(8):3 234-3 242.
  • 9Onda M,Belorgey D,Sharp LK,et al.Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies[J].Biol Chem,2005,280:13 735-13 741.
  • 10Yepes M,Sandkvist M,Wong MK,et al.Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis[J].Blood,2000,96:569-576.

共引文献14

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部